Provided herein is technology relating to compositions containing bioactive fatty acids in combination with one or more non-fatty acid anti-inflammatory drugs, and particularly, but not exclusively, to compositions and methods related to the production and use of non-methylene interrupted fatty acids such as sciadonic acids, juniperonic acid, pinoleic acid and dihomopinoleic acid in combination with one or more anti-inflammatory drugs.